In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...

Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial infarction ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...